Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Organ Cancer”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Testing effectiveness (Phase 2)Looking for participantsNCT04349436
What this trial is testing

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc. 65
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Not applicableStudy completedNCT03378752
What this trial is testing

Atelectasis Formation Using HFJV During Stereotactic Solid Organ Ablations

Who this might be right for
High Frequency Jet VentilationAtelectasis
Karolinska Institutet 25
Testing effectiveness (Phase 2)Study completedNCT03110159
What this trial is testing

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Who this might be right for
Skin CancerNon-melanoma Skin CancerSun Damaged Skin+1 more
Medical Dermatology Specialists 8
Early research (Phase 1)Study completedNCT00095160
What this trial is testing

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors

Who this might be right for
Neoplasms
Masonic Cancer Center, University of Minnesota 42
Large-scale testing (Phase 3)Ended earlyNCT01532453
What this trial is testing

Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Who this might be right for
Actinic KeratosesSquamous Cell Carcinomas
Spirig Pharma Ltd. 244
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Early research (Phase 1)Study completedNCT00054483
What this trial is testing

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+31 more
National Cancer Institute (NCI) 69
Early research (Phase 1)Active Not RecruitingNCT03162627
What this trial is testing

Selumetinib and Olaparib in Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastMalignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital Organs+2 more
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Early research (Phase 1)UnknownNCT00559117
What this trial is testing

A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer

Who this might be right for
Advanced and/or Metastatic Solid Organ Cancer
Vascular Biogenics Ltd. operating as VBL Therapeutics 48
Early research (Phase 1)Study completedNCT01218555
What this trial is testing

Study of Everolimus (RAD001) in Combination With Lenalidomide

Who this might be right for
Solid Organ MalignanciesAdenoidcystic CarcinomaNeuroendocrine Tumors
Emory University 44
Not applicableStudy completedNCT01576653
What this trial is testing

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

Who this might be right for
Invasive Fungal InfectionHematological MalignancyReceipt of Solid Organ Transplant
Robert Krause, MD 100
Early research (Phase 1)Study completedNCT00113113
What this trial is testing

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

Who this might be right for
Tumors
Astex Pharmaceuticals, Inc. 54
Not applicableUnknownNCT02858778
What this trial is testing

Timing of Acute Palliative Care Consultation in Critically Ill Patients

Who this might be right for
Multiple Organ FailureEnd Stage Cardiac FailureEnd Stage Chronic Obstructive Airways Disease+8 more
Wayne State University 120
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Large-scale testing (Phase 3)Study completedNCT04870333
What this trial is testing

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Who this might be right for
Covid19
Cambridge University Hospitals NHS Foundation Trust 2,240
Testing effectiveness (Phase 2)Study completedNCT01397929
What this trial is testing

An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors

Who this might be right for
Solid Organ Tumors
Basilea Pharmaceutica 73
Not applicableLooking for participantsNCT06734091
What this trial is testing

Rapid Processing and Immunohistochemistry Method for Optimising Diagnosis Time in Solid Organ Donors, Suspected Malignancy

Who this might be right for
DonorsOrgan DonorOrgan Transplants
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Load More Results